This may account for the dramatic atheroprotection provided by A20 in the diabetic ApoE-null mouse model via down-regulation of hyperglycemia-dependent and hyperglycemia-independent effectors of atherosclerosis. The gene discussed is APOE; the disease is Hyperglycemia.